2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease

Published: mayo 14, 2024

normal artery and blocked artery
  • Peripheral artery disease (PAD) is a common cardiovascular disease associated with increased risk of amputation, myocardial infarction, stroke, and death, as well as impaired quality of life, walking performance, and functional status.
  • The updated evidence-based recommendations for managing Lower Extremity Peripheral Artery Disease, originally outlined in the 2016 AHA/ACC Guideline, now incorporate the latest research findings to assist clinicians.
  • Furthermore, novel recommendations concerning comprehensive care for individuals with peripheral artery disease have been formulated.
 

2024 Guideline for the Management of Lower Extremity Peripheral Artery Disease

Heather L. Gornik, MD, FAHA, MSVM, Chair; Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM, Co-Vice-Chair; Philip P. Goodney, MD, MS, DFSVS, Co-Vice-Chair discuss highlights of the 2024 ACC AHA Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD). Through a collaborative effort across nine organizations and diverse committee of disciplines, this comprehensive document offers a new framework for understanding PAD's clinical manifestations, introduces new medical therapies and delves into chronic symptomatic PAD, chronic limb-threatening ischemia, and other PAD aspects, underscoring the role of multidisciplinary care and addressing health disparities and research gaps.